CD4 and prostate neoplasm: Accumulating evidence suggests that CD4+ T cells could contribute to a tumor immune evasion and tumor progression.14, 15 Our previous study has shown that CD4+ T cells in the prostate tumor microenvironment contribute to PCa progression,10 and we found increased CD4+ T‐cell infiltration in PCa tissue after Doc treatment.